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Abstract
Sexual dysfunction is associated with pain during sexual intercourse. Diabetes mellitus (DM) has been reported to be one of causal factors for sexual dys-
function in women. This cross-sectional study was conducted to describe status of sexual dysfunction in women with DM in the Tlogosari Kulon Primary Health
Care, Semarang, Indonesia, in March 2017. A total of 103 women with DM visiting the Primary Health Care participated in this study. Data were collected using
a questionnaire-guided interview and through measurements (blood pressure and random blood glucose test). Results showed that 74.8% of women with DM
had sexual dysfunction. The proportion of sexual dysfunction was higher among women in the clinical phase, with uncontrolled blood glucose levels, hyper-
tension grade II, prolonged duration of DM of ≥ 5 years, undergoing insulin treatment, in menopause, grand multiparity, having used the tubectomy contra-
ception method, low physical activity, depression, and consumption of antihypertensive drugs. Three factors showing an increased tendency to cause sexual
dysfunction in women with DM were aging process (Odds Ratio (OR) : 0.294, 95% CI: 0.072 - 1.195, p-value = 0.087), menopausal status (OR : 0.102, 95%
CI: 0.010 - 1.042, p-value = 0.054), and consumption of antihypertensive drugs (OR : 0.153, 95% CI: 0.033 - 0.712, p-value = 0.170). Main factors related to
sexual dysfunction were aging process, menopausal status, and consumption of antihypertensive drugs.
Keywords: Female sexual function index, pathology, physiology, psychosociology, women with diabetes
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Introduction
Sexual dysfunction is a disorder in terms of desire 
for sexual satisfaction and the ability to achieve sexual 
satisfaction.1 Sexual dysfunction can have a major  
impact on the quality of life.2 In women, it is a  
significant reproductive health problem as it is  
associated with the continuity of a woman’s  
reproductive function and can considerably affect the 
harmony of the relationship between husband and wife.3
The etiology of sexual dysfunction in women is 
 multifactorial and combines interpersonal, contextual 
(social), psychological (such as depression, anxiety, 
body image perception disorders, traumatic sexual 
 experience in the past, and history of abuse), and 
 biological factors, including several medical conditions 
(urogenital, neurological, and endocrine disorders, 
menopause, pregnancy, and obesity) as well as
 pharmacological and other the rapies (anti-neoplasmic 
agents, antipsychotic and anti depressant medications, 
antihypertensive agents, major surgical operations, 
 radiation therapies). The risk factors for female sexual 
dysfunction comprising the social and cultural aspects 
include a lack of social relationships, poverty,  
 employment status, religious life, educational  
background, and limited sport activity.4,5
Sexual dysfunction in women with DM is known for 
a long period of time; however, most studies have not 
described this condition.6,7 Moreover, results of  several 
studies on pathogenetic factors of sexual dys function still 
remain controversial.5,8–10
One study reported no difference in sexual  
 dysfunction between premenopausal (62.1%) and 
 postmenopausal (62.5%) women, but a greater  
 incidence of sexual dysfunction was found in women
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Care, Semarang City, in March 2017. The study
 population included women with DM who visited the
Tlogosari Kulon Primary Health Care in 2016. A total of
158 subjects were recruited using the total sampling
method.
The inclusion criteria were female patients with DM
diagnosed at the Tlogosari Kulon Primary Health Care
and willing to participate in the study. The final study
samples included a total of 103 women. A total of 55
subjects had to be excluded from the study, including 29
who did not have spouse, 4 who died, 12 who refused to
participate, and 10 subjects who moved. Data were
 collected through a questionnaire-guided interview. The
study protocol was reviewed and approved by the
Committee of Public Health Research Ethics,
Diponegoro University (No.52/EC/FKM/2017).
Informed written consent was obtained from each
 res pondent after providing information about the study.
Women with DM who fulfilled the inclusion criteria
were informed about the purpose, benefit, and procedure
of this study. Those who agreed to participate were asked
for a written informed consent by the interviewer. This
was followed by an interview guided by a questionnaire.
Demographic data of the participants were collected
through FSFI questionnaires, the Beck Depression
Inventory (BDI) questionnaires, and Global Physical
Activity Questionnaire (GPAQ).
In this study, sexual dysfunction was described on the
basis of psychosocial (education level, employment sta-
tus, and depression status), physiological (age,
menopausal status, parity, BMI, and physical activity),
pathological (blood sugar level, blood pressure, and
 duration of diabetes), and pharmacological (type of
 treatment, antihypertensive drug consumption, and
 contraceptive method) factors. The total four sections of
the questionnaire were divided into 19 questions of FSFI,
21 questions of Beck Depression Inventory-II, and 15
questions of GPAQ that cover the respondents’
 demographic details, menopausal status, contraception
method, duration of diabetes, type of diabetic treatment,
and consumption of antihypertensive drugs. Weight,
height, blood pressure, and blood sugar levels (random
blood sugar test) of the respondents were also measured
in this study.
Disorders occur in one or more of the overall normal
sexual response cycle. The toal of questions was
 amounted to 19 pieces. Classification of sexual
 dysfunction: 1. Desire, No. Question: 1,2, Score range:
1––5, Multiplication factor: 0.6. 2. Arousal No. question:
3,4,5,6, Score range: 0–5, Multiplication factor: 0.3. 3.
Lubrication, No. Question: 7,8,9,10, Score range: 0–5,
Multiplication factor: 0.3, 4. Orgasm, No. Question:
11,12,13, Score range: 0–5, Multiplication factor: 0.4, 5.
Satisfaction, No. Question: 14,15,16, Score range: 0–5,
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from 50 years of age onward. Age was found to 
 negatively correlate with the female sexual function  
index (FSFI) score (ρ = −0.324, p-value < 0.001).11 The 
prevalence of sexual dysfunction was significantly higher 
among the study group than in the control group. The 
study also found that with an increase in blood glucose 
(HbA1c) levels, body mass index (BMI), and duration of 
diabetes, the prevalence of sexual dysfunction also  
increased.12
The prevalence rates of sexual dysfunction in women 
with diabetes mellitus (DM) and in the control  
 population have been reported to be 88% and 80%, 
 respectively. The mean (standard deviation) FSFI score 
in women with DM was significantly lower than that in 
the control group (16.2 [9.5] vs. 21 [8.5], p-value = 
0.02). DM demonstrated a clear association with the 
risk of sexual dysfunction in women.13 Based on prior 
study, the negative correlation of age was found to be 
the most powerful and meaningful to all domains 
(desire, arousal, lubrication, orgasm, satisfaction, and 
sexual pain) and total score, followed by the duration of 
DM.14 The mean values for arousal, lubrication, 
dyspareunia, and orgasm were significantly lower only 
in the type-1 DM group than in the control group. The 
mean values for desire were lower in type-1 and type-2 
DM groups than in the control group.15 In another 
study, the mean values for desire, arousal, lubrication, 
orgasm, satisfaction, and pain were significantly lower 
in both type-1 and type-2 DM groups than in the 
control group.13 In contrast, one study had reported 
that the duration of DM showed no association with 
sexual dysfunction in women with DM among the 
study population.16 Nevertheless, several studies 
have reported an association between the  
duration of DM and sexual dysfunction.9,17 Coexisting 
depression has also been reported to have a general link 
with sexual dysfunction in women with DM.8,18
Although sexual dysfunction in men due to the  
complications of DM has been well explained, the 
sexual problems of women with DM and their 
relationship with the risk factors still remain less 
understood and have not received much attention.5 On 
the other hand, sexual  dysfunction can have a 
significant effect on the quality of life. In fact, it is still 
necessary to investigate the  factors associated with 
sexual dysfunction in women with DM. Based on the 
above-described information, this descriptive study was 
conducted to explore the issue of sexual dysfunction in 
women with DM at a Primary Health Care in 
Semarang, Central Java Province, Indonesia.
Method
This descriptive cross-sectional study was conducted 
to measure the prevalence of sexual dysfunction in 
women with DM in the Tlogosari Kulon Primary Health
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Multiplication factor: 0.4, 6. Sexual pain, No. Question: 
17,18,19, Score range: 0–5, Multiplication factor: 0.4. 
The total score was obtained at a minimum of 1.2 and a 
maximum score of 36 with a cut-off of 63.6 for each 
 domain and a cut-off of 26.5 for all domains. Thus, the 
category was termed as sexual dysfunction when the FSFI 
score was ≤ 26.5. The variable of stressful work was 
measured using the International Stress Management 
Association (ISMA) questionnaire.19 According to the 
ISMA, a person was cate gorized to have stress if he/she 
obtained a score was > 14 points and to have no stress if 
the score is < 14 points. Physical activity was measured 
using the GPAQ.20 Based on the recommendation by 
WHO, a total physi cal activity metabolic equivalent 
turnover (MET) minutes per week of < 600,20 was  
classified as low physical activity, 600–1500 MET  
minutes per week was classified as moderate, and more 
than 1500–3000 MET minutes per week was classified 
as vigorous physical activity. Information regarding 
 variables such as the aging process, employment status, 
education, sexual desire le vel, consumption of  
 hypertensive and antidepressant drugs, and smoking 
 status was directly collected from the participant using a 
questionnaire. Obesity was measur ed using digital weight 
scales and microtoise, whereas central obesity was 
 measured using Metline. Blood sugar level and duration 
of diabetes were collected from the patient’s medical 
record data. Variable aging process is a process of 
 disappearing slowly the abili ty of tissue to repair itself 
and maintain its normal structure and function, so that it 
cannot correct the deficiencies suffered. The categories 
of aging process included the clinical phase (age ≥ 46
years), the transition phase (age 36 - 45 years), and the 
subclinical phase (age 25 - 35 years).21
Multivariate analysis was used to investigate the 
 collected data. Before inputting the data into the logistic 
model, a bivariate analysis was conducted to assess the 
aforementioned independent variables. When the     chi-
square test revealed significant or nearly signifi cant 
 effects (p-value < 0.05), the variable was considered as 
the predictor in the multiple logistic regression model 
and stepwise forward and backward procedures were 
performed. Finally, the goodness-of-fit test (Hosmer and 
Lemeshow test) was conducted to assess whether the 
 final model was suited to the data. By excluding the least 
significant variable from the model, a reduction in value 
was observed, hence that this variable was retained in 
the model. Odds ratios (OR) were also calculated.
Results
In Table 1, of the 103 women with DM, 74.8% had
Table 1. Sexual Function Disorder Domain Based on Female Sexual Function
Index Scores
Female Patients with DM
Domain Mean ± SD
f %
HSDD 2.3 ± 1.2 54 52.4
FAD 2.1 ± 2.0 34 33.0
Lubrication 2.3 ± 2.2 26 25.2
FOD 2.5 ± 2.2 22 21.4
Satisfaction 2.5 ± 2.4 23 22.3
SPD 3.0 ± 2.7 15 14.6
Notes: DM (Diabetes Mellitus), HSDD (hypoactive sexual desire disorder),
FAD (female arousal disorder), FOD (female orgasmic disorder), SPD (sexual
pain disorder)
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Table 2. Distribution of Respondents Based on Psychosocial Factors and Physiological Factors
Sexual Function
Factors Variable Category Woman with DM 
(n = 103)      Dysfunction Normal
Psychosocial          Level of education           Elementary school 41 (39.8%) 33 (80.5%)                8 (19.5%)
Junior high school 24 (23.3%)  18 (75.0%) 6 (25.0%)
Senior high school 32 (31.1%)  22 (68.8%) 10 (31.3%)
Higher education 6 (5.8%)      4 (66.7%) 2 (33.3%)
Employment status          Housewife 75 (72.8%) 58 (77.3%) 17 (22.7%)
Employed 28 (27.2%)     19 (67.9%) 9 (32.1%)
Depression status             Depression 27 (26.2%) 24 (88.9%) 3 (11.1%)
Normal 76 (73.8%)                  53 (69.7%) 23 (30.3%)
Physiological         Aging process Clinical phase 90 (87.4%) 71 (78.9%)             19 (21.1 %)
Transition phase 8 (7.8%)       5 (62.5%) 3 (37.5 %)
Subclinical phase 5 (4.9%)      1 (20.0 %) 4 (80.0%)
Menopausal status           Yes 75 (72.8%) 61 (81.3%) 14 (18.7%)
No 28 (27.2%)                  16 (57.1%) 12 (42.9%)
Parity Grand multiparity 21 (20.4%) 17 (81.0%) 4 (19.0%)
Multiparity 70 (68.0%)      56 (80.0%) 14 (20.0%)
Primiparity 9 (8.7%)                    3 (33.3%) 6 (66.7%)
Nulliparity 3 (2.9%)                    1 (33.3%) 2 (66.7%)
BMI Obesity 52 (50.5%)    38 (73.1%) 14 (26.9%)
Normal 48 (46.6%)                  37 (77.1%) 11 (22.9%)
Underweight 3 (2.9%)        2 (66.7%) 1 (33.3%)
Physical activity Light 8 (7.8%)    8 (100.0%) 0 (0.0%)
Moderate 81 (78.6%)      59 (72.8%) 22 (27.2%)
Heavy 14 (13.6%)                  10 (71.4%) 4 (28.6%)
Notes: BMI = Body Mass Index, DM = Diabetes Mellitus
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The majority of women with systolic and diastolic
blood pressure were categorized as prehypertensive 
(46.6% and 43.7%, res pectively, Table 3). The  
proportion of sexual dysfunction was higher among those 
who had grade II systolic hypertension (94.1%), and 
grade II diastolic hypertension (81.0%). Most of the 
women with DM (78.6%) used oral hypoglycemic agents 
(OHAs) (Table 4). Regarding contraceptive use,  
approximately half of the respondents (48.5%) had a 
record of using hormonal contraceptives (pills, injection, 
and implants).  
The majority of study participants (77.1%) visiting 
the Tlogosari Kulon Primary Health Care had diabetes 
for less than 5 years (Table 5). The longest duration of 
DM was 21 years, and the shortest was 4 months, with 
an average duration of 4.3 years. Most of them (77.8%) 
had uncontrolled blood sugar levels (> 200 mg/dL), with 
an average level of 261.6 mg/dL. Moreover, most of them 
(65.7%) did not take antihypertensive drugs. The 
 proportion of sexual dysfunction was higher among those 
who used insulin (87.5%), tubectomy contraceptives 
(82.4%), and antihypertensive drugs (93.9%).
Based on multivariate analysis (Table 6), three  
factors were found to increase the risk for sexual  
dysfunction in women with DM: aging process (p-value 
= 0.087; OR = 0.294), menopausal status (p-value = 
0.054; OR = 0.102), and consumption of antihyperten-
sive drugs (p-value = 0.170; OR = 0.153).
Table 4. Distribution of Respondents Based on Pharmacological Factors
Sexual Function
Variable Category Woman with DM
(n = 103) Dysfunction      Normal
Type of treatment OHA 81 (78.6%) 61 (75.3%)        20 (24.7%)
Insulin 8 (7.8%) 7 (87.5%)          1 (12.5%)
OHA + insulin 3 (2.9%) 2 (66.7%)          1 (33.3%)
Diet + exercise 11 (10.7%) 7 (63.6%)          4 (36.4%)
Contraceptive method        Hormonal 50 (48.5%) 38 (76.0%)        12 (24.0%)
Tubectomy 17 (16.5%) 14 (82.4%)          3 (17.6%)
IUD 10 (9.7%) 6 (60.0%)          4 (40.0%)
None 26 (25.2%) 19 (73.1%)          7 (26.9%)
Notes: OHA = Oral Hypoglycemic Agents, IUD = Intra-Uterine Device
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sexual dysfunction. The most affected domain was 
 hypoactive sexual desire disorder (HSDD; 52.4%), 
whereas the least affected domain was sexual pain 
 disorder (SPD; 14.6%).
More than one-third (39.8%) of women with DM 
 attending the Tlogosari Kulon Primary Health Care had 
e lementary school level of education (Table 2). The  
majority of res pondents (72.8%) were housewives. 
Regarding the level of depression, most of the  
 respondents (73.8%) had normal depression levels. 
Based on the psychosocial factors, the proportion of 
 sexual dysfunction was higher among those with a 
 primary education (80.5%).
Viewed from the perspective of antiaging process, the 
majority of women aged > 45 years with DM (87.4%) 
visiting the Tlogosari Kulon Primary Health Care were 
in the clinical phase (Table 2). More than half of them 
(50.5%) had obesity according to BMI status. The 
 majority of them (78.6%) had moderate physical activity. 
Most women with DM (68.0%) were included in the 
multipari ty group (2–4 births), and 72.8% of them had 
experienced menopause. Based on the physiological 
 factors, the proportion of sexual dysfunction was higher 
among women with DM in the clinical phase of aging 
process (78.9%), in menopause (81.3%), and those with 
grand multiparity (81.0%), normal BMI status (77.1%), 
and low physical activity (100.0%).
Table 3. Distribution of Respondents Based on Pathological Factors
Women Sexual Function
Variable Category with DM
(n = 103) Dysfunction        Normal
Systolic blood pressure        Hypertension grade II        17 (16.5%) 16 (94.1%)             1 (5.9%)
Hypertension grade I          23 (22.3%) 17 (73.9%)           6 (26.1%)
Prehypertension 48 (46.6%) 34 (70.8%)         14 (29.2%)
Normal 15 (14.6%) 10 (66.7%)           5 (33.3%)
Diastolic blood pressure      Hypertension grade II        21 (20.4%) 17 (81.0%)           4 (19.0%)
Hypertension grade I          20 (19.4%) 16 (80.0%)           4 (20.0%)
Prehypertension 45 (43.7%) 32 (71.7%)         13 (28.9%)
Normal 17 (16.5%) 12 (70.6%)           5 (29.4%)
Notes: DM = Diabetes Mellitus
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Discussion
Diabetes causes dysfunctions of blood vessels and 
nerves, which lead to structural and functional changes 
in the female genitals, thereby disrupting the sexual 
 res ponses. Furthermore, hyperglycemia can reduce the 
hydration of mucous membranes, including the vaginal 
ti ssues, causing reduced vaginal lubrication and  
 dyspareunia. Hyperglycemia potentially triggers  
 dyspareunia due to its association with increased  
incidence of genitourinary infections.5,22 The hormonal 
imbalance accompanying DM also plays a vital role in 
the pathogenesis of sexual dysfunction in women. 
Diabetes also causes complications such as blood flow 
disruptions to sexual organs and hypogonadism, which 
present as abnormal hypophysical and hypothalamic 
functions.9,22,23 In this study, sexual dysfunction was 
found in 74.8% of women with DM, which is consistent
with a study in 2015 that reported an incidence of 
78.7%.18 However, a later study conducted in 2016  
reported an incidence of 55.9% of sexual dysfunction in 
women with DM.17 Studies have also demonstrated that 
sexual dysfunction is prevalent in both women and men 
with DM.6,24,25
The results of this study demonstrated that women 
with DM and grade II hypertension were at risk of 
 developing sexual dysfunction. The higher the blood 
pressure, the lower the sexual function. This result was 
consistent with studies conducted in Turkey, which 
 reported that the average FSFI score of women with 
 hypertension (19.6) was lower than that of women 
 without hypertension (22.4), with a significant difference 
(p-value = 0.012). In addition, there was a mean 
 difference in the FSFI scores on the domains of desire, 
arousal, orgasm, and satisfaction (p-value < 0.05),
Table 6. Results of Multivariate Analysis
Independent Variable p-Value OR (95% CI)
Aging process 0.087 0.294 (0.072–1.195)
Menopausal status 0.054 0.102 (0.010–1.042)
Consumption of antihypertensive drugs 0.170 0.153 (0.033–0.712)
Notes: CI = Confidence Interval, OR = Odd Ratio
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Table 5. Association of Independent Variables with Sexual Dysfunction Status among Women
Sexual Function
Variable Category p-Value            OR (95% CI)
Dysfunction              Normal
Employment status Housewives 58 (77.3%)            17 (22.7%)           0.325           1.616 (0.61-4.22)
Employed 19 (67.9%) 9 (32.1%)
Level of depression Depression 24 (88.9%) 3 (11.1%)           0.049         3.472 (0.95-12.69)
Normal 53 (69.7%)            23 (30.3%)
Aging process Clinical and transition phase 76 (77.6%)            22 (22.4%)           0.014     13.818 (1.46-130.07)
Subclinical phase 1 (20.0%) 4 (80.0%)
Menopausal status Yes 61 (81.3%)            14 (18.7%)           0.012         3.268 (1.2–6–8.42)
No 16 (57.1%)            12 (42.9%)
Parity Yes 76 (76.0%)            24 (24.0%)           0.156            6.33 (0.55–72.9)
No 1 (33.3%)              2 (66.7%)
BMI Overweight and underweight 40 (72.7%)            15 (27.3%)           0.612          0.793 (0.32–1.94)
Normal 37 (77.1%)            11 (22.9%)
Physical activity Low and high 18 (81.8%) 4 (18.2%)           0.390          1.678 (0.51–5.51)
Moderate 59 (72.8%)            22 (27.2%)
Duration of DM ≥ 5 years 27 (77.1%) 8 (22.9%)           0.689          1.215 (0.46–3.15)
< 5 years 50 (73.5%)            18 (26.5%)
Consumption of  Yes 31 (93.9%) 2 (6.1%)           0.002          8.087 (1.78–36.7)
antihypertensive drugs No 46 (65.7%)            24 (34.3%)    
Blood sugar levels Uncontrolled 56 (77.8%)            16 (22.2%)           0.282          1.667 (0.65–4.29)
Controlled 21 (67.7%)            10 (32.3%)
Systolic blood pressure             Hypertension 67 (76.1%)            21 (23.9%)           0.521          1.599 (0.49–5.19)
Normal 10 (66.7%) 5 (33.3%)
Diastolic blood pressure           Hypertension 65 (75.6%)            21 (24.4%)           0.761          1.290 (0.40–4.08)
Normal 12 (70.6%) 5 (29.4%)
Level of education Elementary and high school 73 (75.3%)            24 (24.7%)           0.641            1.52 (0.26–8.83)
Higher education 4 (66.7%) 2 (33.3%)
Contraceptive use Yes 58 (75.3%)            19 (24.7%)           0.820          1.125 (0.41–3.08)
No 19 (73.1%)   7 (26.9%)
Contraceptive method Tubectomy 14 (82.4%) 3 (17.6%)           0.551          1.704 (0.44–6.46)
Others and none 63 (73.3%)            23 (26.7%)
Notes: BMI = Body Mass Index, DM = Diabetes Mellitus, OR = Odd Ratio, CI = Confidence Interval
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cessation of fertility, the other effects of menopause 
 include psychological changes that trigger a negative 
 attitude in postmenopausal women and increase their 
susceptibility to depression.33,34 The incidence of sexual 
dysfunction among postmenopausal women has been  
reported to be almost 80%.35 This result was consistent 
with a study conducted in New York City, which reported 
that the incidence of sexual dysfunction in  
 postmenopausal women was at 70.9%. Another study 
 involving 370 women aged 40–65 years reported that 
67% of them experienced sexual dysfunction and 
 postmenopausal women had two times greater risk for 
sexual dysfunction than premenopausal women.36
A limitation of this study is that there could have been 
a bias in the information, probably for variables such as 
sexual function disorder and level of depression, as these 
variables were directly enquired with the participants
 u sing questionnaires at their house in the evening when
their spouse was also present. Hence, respondents might
have been reluctant to give an honest response regarding
their depression status, whether it existed or not, and the
sexual function disorders they have. It is also possible
that because the interviews were conducted in the
 afternoon or evening after working hours, the
 respondents could have answered as needed due to
 fatigue. The strength of this study is that it reports the
proportion of sexual dysfunction among women through
which its risk factors can be identified, so that the related
authorities can implement promotional and preventive
measures.
Conclusion
In this study, three factors found to increase the risk
for sexual dysfunction in women with DM were aging
process, menopausal status, and consumption of
 anti hypertensive drugs. The higher the blood pressure,
the  lower the sexual function in women with DM due to
the consumption of antihypertensive drugs, which
 inhibits blood flow to the genital organs. This study also
de monstrated that the higher the age, the lower the FSFI
score or the sexual function, because in the clinical phase,
the presentations of aging begin to be clearly  visible,
 especially decreased libido. In terms of sexual
 functioning, the major effects of the reduction of es trogen
levels during menopause are the physical and
 psycho logical changes, such as the vaginal dryness and
atrophy due to reduced blood flow, resulting in
 dyspa reunia that in turn causes uncomfortable sexual
 activity and might also lead to depression.
Regarding the limitation, the authors clearly state that
biased information was inevitable and might affect the
results of this study. The cause of the biased information
in this study was the involvement of other people who
were not respondents in answering the questions;
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whereas there was no difference in the average FSFI 
score on the lubrication and pain domains.17 Vascular 
dysfunction due to hypertension could lead to disruption 
of blood flow and clitoral function as erectile organs in 
women.26 High blood pressure could be a causal factor 
for a person’s low sexual passion.
However, the use of antihypertensive drugs also has a 
negative impact on the sexual appetite, especially 
diuretic medicines and beta-blockers.27 These medicines 
work by reducing and maintaining a low blood pressure 
when blood flows to the genital organs, which would 
ultimately inhibit blood flow to the genital organs. 
Thus, these  individuals could experience difficulty in 
obtaining and maintaining an erection or orgasm, 
thereby causing  sexual dysfunction.28 The problem that 
generally arises in women is the lack of production of 
vaginal fluids that serve as a lubricant during 
intercourse.27
This study demonstrated that the higher the age, the 
lower the FSFI score or the sexual function. Persons in 
the age of the clinical phase (> 45 years) were more 
likely to suffer from sexual dysfunction than those in 
the  subclinical phase and transition phase, which is 
because in the clinical phase, the presentations of aging 
begin to be clearly visible, including hair loss, skin 
wrinkles, high blood pressure, diabetes, heart problems, 
memory loss, and decreased libido.29,30 Several studies 
have reported that sexual function decreases with age. 
Increasing age leads to a decrease in testosterone levels, 
which in turn are associated with decreased sexual 
desire in both men and women. Thus, the incidence of 
sexual dysfunction increases with age.31 Women in the 
third phase or the clinical phase are not included 
in the women of   childbearing age category. Women 
in the women of childbearing age category are defined 
as those whose  reproductive organs functioned well 
between the age of 20 and 45 years.32 In this study, 
most of the women with DM were not classified in the 
women of childbearing age category. This result was in 
accordance with a study  conducted in West Jakarta that 
demonstrated that age affected sexual dysfunction 
in women. The most  dominant variable associated 
with sexual dysfunction was age (p-value = 0.007, OR = 
3.45). Elderly people had three times greater risk of 
developing sexual  dysfunction than younger 
individuals.32
In addition, this study has shown that menopausal 
women with DM tend to suffer from sexual dysfunction 
compared with women without DM. Women experience 
major hormonal changes associated with menopause, 
one among which is a decrease in estrogen levels. In 
terms of sexual functioning, the major impact of the  
reduction of estrogen levels is vaginal dryness and  
atrophy caused due to reduced blood flow, resulting in 
dyspareunia that in turn causes uncomfortable sexual  
activity. Besides causing physiological changes such as
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 however, this could be minimized by inviting the
 respondents to a place far from the crowd before the in-
terview began.
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